← FDA Drug Approvals (Drugs@FDA)

NYPOZI

BLA · Biologics License Application · Sponsor: TANVEX BIOPHARMA USA INC · Approved 2024-06-28

Drug application

FDA Application #
BLA761126
Application type
Biologics License Application
Brand name
NYPOZI
Generic name
FILGRASTIM-TXID
Active ingredients
FILGRASTIM-TXID
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
TANVEX BIOPHARMA USA INC
Manufacturer
Tanvex BioPharma USA, Inc.
First approval
2024-06-28

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown